Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph phase_1
1
33%
Ph phase_4
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (33.3%)
Phase 42 (66.7%)

Trials by Status

terminated133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_4

Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy

NCT05804071
unknownphase_1

Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome

NCT02656225
terminatedphase_4

Prevalence and Treatment of Anemia in Rehabilitation Patients

NCT00511901

Clinical Trials (3)

Showing 3 of 3 trials
NCT05804071Phase 4

Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy

Unknown
NCT02656225Phase 1

Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome

Unknown
NCT00511901Phase 4

Prevalence and Treatment of Anemia in Rehabilitation Patients

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3